Skip to main content
. 2013 Sep;49(3):403–409. doi: 10.1165/rcmb.2013-0100OC

Figure 3.

Figure 3.

Ataluren corrects miR processing in endothelial cells and pulmonary artery smooth muscle cells (PASMCs). Cells were treated with 15 μM ataluren for 24 hours, then BMP9 (PAEC, L-EPC) or BMP4 (PASMC) for 4 hours. RNA was analyzed for miR-27a, normalized to RNU48. Results are shown as fold change of miR-27a with BMP treatment compared with vehicle. Means (±SEM) of nine replicates are shown.